Skip to the page

Data / Form D filings / Atacama Therapeutics, Inc.

Atacama Therapeutics, Inc.: Form D filings

Atacama Therapeutics, Inc., a health care company in Wellesley, MA, filed 2 Form D notices with the SEC in 2024. The latest, on May 7, 2024, reports $830,000 sold of a $4.7 million offering to 16 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
65 WILLIAM STREET, SUITE 200, Wellesley, MA, 02481
Phone
(617) 225-7700
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2022176

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 7, 2024Amendment$4,725,000$830,000$3,895,00016Apr 26, 2024sec.gov
May 6, 2024New notice$4,725,000$830,000$3,895,00016Apr 26, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joseph BaronExecutive Officer, Director
Jonathan ReisDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of May 6, 2024 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Atacama Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.